Houttuynia — Benefits Deep Dive

Houttuynia cordata is dokudami in Japan, eo or diếp cá in Vietnam, and yu xing cao — "fish-smell herb" — in Chinese medicine. It is a genuine everyday food: eaten raw by the handful on the Vietnamese herb platter, sold as the crunchy white rhizome zhé'ěrgēn in the markets of Guizhou and Sichuan, and drunk as a common household tea across Japan and Korea. That culinary record is long, broad and human, and it should be stated plainly rather than hedged — it is the strongest safety datum this plant has.

And there is a real safety event that has nothing to do with any of it. Injectable Houttuynia preparations, used at scale in Chinese hospitals, caused serious allergic and anaphylactic reactions, and in 2006 China's drug regulator suspended or restricted them. That signal is genuine and it should not be softened. It is also not evidence that a bowl of the herb or a cup of the tea carries the same risk. An injection skips digestion, the intestinal wall, the gut microbiome and hepatic first pass entirely, and delivers the whole dose as a bolus into a compartment lined with mast cells. A different route is a different intervention — and this is the clearest case on the site of why that principle matters, because here it runs in the protective direction.

Hold both halves at once and the plant comes into focus. Never take an injectable Houttuynia product. Eat the vegetable and drink the tea if you like the taste. Be more sceptical of a capsule than of either, because a concentrated extract is a third exposure that inherits the reassurance of neither the food nor the tradition.

The antiviral research is the reason for modern interest, and these pages take it seriously enough to take it apart. Steam-distilled Houttuynia inactivates enveloped viruses on contact in a test tube; there is influenza and coronavirus work including from the SARS and COVID periods; the named constituents are quercitrin, hyperoside, rutin and the volatile aldehyde houttuynin (decanoyl acetaldehyde). But quercitrin and rutin belong to half the plant kingdom, so a quercitrin result is not a Houttuynia result; houttuynin is volatile and unstable, so an ethanolic extract and a brewed tea are not the same material; and adequate controlled human trials are absent — not negative, absent. Nobody ran one and failed. Nobody ran one.

Table of Contents

1. Deep-Dive Articles
2. The One Distinction to Carry Away
3. Evidence Ledger
4. Key Research: The Injectable Reactions
5. Key Research: Antiviral and Respiratory
6. Key Research: Chemistry and Preparation
7. Key Research: Aristolochic Acids and Identity
8. Key Research: Food, Tradition and Borrowed Claims
9. External Resources
10. Connections

Deep-Dive Articles

The One Distinction to Carry Away

If a reader takes a single thing from this section, it should be the difference between these four exposures. They are routinely discussed as one plant with one risk profile, and they are not:

1. Fresh leaf or rhizome as food. Long, broad, multi-country human record across raw and cooked forms. Self-limiting quantities because the herb is pungent. Nothing on this site argues against it.
2. Dried herb tea, a few cups a day. Equally long a record, and the form with the least of the volatile chemistry — roasting drives off nearly all the aldehydes, which is exactly why people who cannot face the raw leaf drink dokudami-cha happily.
3. Concentrated extract capsules. No traditional record, unstated concentration factor, no long-term human data, and the form for which the open questions genuinely apply. Anyone defending this one with "eaten safely for centuries" is performing a transfer that does not hold.
4. Injectable preparations. Serious anaphylactic reactions, a 2006 regulatory suspension, and the one hard rule on these pages: never use one. They are not legally marketed outside China.

The route argument protects item 1 and item 2 specifically. It does not stretch to item 3, and it is the reason item 4 is in a category of its own.

Evidence Ledger

Ranked against the popular narrative rather than with it. Notice where the well-established entries sit: the three best-supported facts about this plant are all safety facts, and two of them are reassuring.

1. Established, human, adverse. Injectable Houttuynia products caused serious immediate hypersensitivity reactions and were restricted in 2006.
2. Established, analytical, reassuring. Tandem mass spectrometry of correctly identified H. cordata found aristolochic acids absent or below the detection limit.
3. Established, dietary, reassuring. Long, broad culinary use across four food traditions with no recognised food-borne toxicity syndrome.
4. Established, in vitro. The steam distillate inactivates enveloped viruses on contact; non-enveloped poliovirus is unaffected, which is the internal consistency you would want from a membrane-disruption mechanism.
5. Preliminary, animal and enzymatic. Influenza and SARS-CoV work, immunomodulation in mice, biofilm inhibition in culture, and one mouse study of the plant's aristolactams.
6. Weak, human. One unblinded, actively controlled trial of a Houttuynia-containing multi-herb formula in allergic rhinitis. Formula substitution makes single-component attribution unsound.
7. Absent, human. Every clinical antiviral claim. Also: pharmacokinetics, interaction studies, pregnancy data for medicinal doses, paediatric data, and any long-term study of concentrated extract.
8. Traditional. Centuries of use for lung heat, general detoxification and skin-and-bowel complaints — three traditions that do not converge on one indication, and none of which claimed to treat an infection in the modern sense.

Item 7 is the pivotal line, and its wording is deliberate. Absent is not negative. An intervention whose trials failed is in a different epistemic position from one never tested; collapsing the two flatters the untested claim and unfairly damns the tested one. Houttuynia's antiviral claims have not been refuted. They have never been examined in a person under controlled conditions.

Key Research: The Injectable Reactions

All citations on this hub are given as PubMed searches rather than fixed identifiers, so a reader lands on the live record even where a secondary source has a volume or page wrong. Where a paper's metadata could not be verified, a topic search is linked instead of a citation asserted — and for the injectable adverse events and the regulatory action in particular, this section describes outcomes rather than asserting case counts or a precise regulatory citation.

1. Adverse events to Houttuynia injection: a systematic review — Journal of Evidence-Based Medicine, 2010. The traceable synthesis of published reports; the picture is dominated by immediate hypersensitivity rather than organ toxicity. PubMed search.
2. Mrgprb2 and anaphylactoid reactions induced by Houttuynia cordata injection — Journal of Ethnopharmacology, 2022. Points at direct mast-cell activation, which explains reactions on a first dose. PubMed search.
3. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions — Nature, 2015. Background: how MRGPRX2 produces anaphylaxis-like reactions with no IgE involved. PubMed search.
4. Polysorbate 80 hypersensitivity — the solubiliser used in traditional-medicine injectables, which has its own anaphylactoid record and complicates attribution. PubMed search.
5. Traditional Chinese medicine injections and adverse drug reactions — the wider product class, which is the correct comparison group. PubMed search.

Key Research: Antiviral and Respiratory

1. Virucidal effects of the steam distillate from Houttuynia cordata on HSV-1, influenza virus and HIV — Planta Medica, 1995. The foundational contact-virucidal result; poliovirus unaffected. In vitro only. PubMed search.
2. Immunomodulatory and anti-SARS activities of Houttuynia cordata — Journal of Ethnopharmacology, 2008. Enzyme-inhibition assays against SARS-CoV targets plus mouse lymphocyte effects; no infected-animal or human endpoint. PubMed search.
3. Houttuynia cordata and influenza virus — the cell-culture and murine influenza literature. PubMed search.
4. Houttuynia cordata and SARS-CoV-2 — the COVID-era docking, network-pharmacology and screening papers. Volume of publications is not weight of evidence. PubMed search.
5. A Houttuynia cordata-based Chinese herbal formula and allergic rhinitis symptoms — Journal of the Chinese Medical Association, 2022. Multi-herb, unblinded, active control. Hypothesis-generating at best, and rhinitis is not a viral illness. PubMed search.
6. Antibiofilm and anti-inflammatory activities of Houttuynia cordata decoction for oral care — Evidence-Based Complementary and Alternative Medicine, 2017. In vitro, but the one setting where a contact mechanism would be clinically plausible — and it has never been trialled as a rinse. PubMed search.

Key Research: Chemistry and Preparation

1. Houttuynia cordata Thunb.: a comprehensive review of traditional applications, phytochemistry, pharmacology and safety — Phytomedicine, 2024. The broad modern review, and the best single place to see how thin the human column is. PubMed search.
2. Volatile composition of Houttuynia cordata — houttuynin (decanoyl acetaldehyde), 2-undecanone, decanal and dodecanal, and how drying and heating change the profile. PubMed search.
3. Sodium houttuyfonate — the shelf-stable bisulfite adduct made because houttuynin will not survive in a bottle. Much of the "Houttuynia" drug literature is really about this manufactured compound. PubMed search.
4. Houttuynoids — the flavonoid–aldehyde adducts genuinely characteristic of this genus, as opposed to its borrowed flavonoids. A much thinner literature, and no human data. PubMed search.
5. Quercetin and rutin bioavailability in humans — why plasma concentrations after realistic intake sit orders of magnitude below antiviral assay concentrations. PubMed search.

Key Research: Aristolochic Acids and Identity

1. Analysis of aristolochic acids in Houttuynia cordata by liquid chromatography–tandem mass spectrometry — Journal of Mass Spectrometry, 2021. Aristolochic acids I and II absent or below a low nanogram-per-gram limit across twenty fresh and sun-dried samples. The decisive paper. PubMed search.
2. Safety evaluation of aristolactams from the edible herb Houttuynia cordata — Food Research International, 2025. Mouse comparison against aristolochic acid I, with a pharmacokinetic explanation for the difference. One study, one species. PubMed search.
3. Rapidly progressive interstitial renal fibrosis in young women: association with a slimming regimen including Chinese herbs — The Lancet, 1993. The Belgian episode, caused by Aristolochia fangchi supplied in place of Stephania tetrandra. PubMed search.
4. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) — New England Journal of Medicine, 2000. The cancer follow-up. PubMed search.
5. Aristolochic acid and the etiology of endemic (Balkan) nephropathy — PNAS, 2007. PubMed search.
6. DNA barcoding for herbal product authentication — ITS2, rbcL and psbA-trnH markers, and why "standardised to X%" says nothing about which plant is in the jar. PubMed search.

Key Research: Food, Tradition and Borrowed Claims

1. Houttuynia cordata as an edible vegetable — the food-science literature on leaf and rhizome composition and use. PubMed search.
2. Micronised purified flavonoid fraction in haemorrhoidal disease — the randomised evidence the Vietnamese haemorrhoid claim borrows from. It belongs to diosmin and hesperidin, at gram-scale purified doses, not to a glass of blended leaf. PubMed search.
3. Phlebotonics for haemorrhoids — systematic review — the class-level assessment, for judging how strong that borrowed evidence actually is. PubMed search.
4. Herbal diuretics — human evidence — how rarely traditional diuretic claims have been tested with urine-volume or natriuresis endpoints, and why "I drank three cups of tea" is a confound nobody controlled for. PubMed search.
5. Elderberry and Andrographis randomised trials in respiratory infection — the comparator literature proving that trials of this kind are entirely feasible for herbal products, and simply have not been run here. PubMed search.

External Resources

• PubMed — the US National Library of Medicine's index of the biomedical literature; every citation above resolves here.
• NCCIH — Herbs at a Glance — plain-language summaries from the US National Center for Complementary and Integrative Health.
• LiverTox (NIH) — the reference on herb- and drug-induced liver injury.
• IARC Monographs — the WHO cancer agency's classifications, including aristolochic acid.
• World Flora Online — accepted plant names and family placement.
• Cochrane Library — systematic reviews, including of natural products for respiratory infection.
• USDA FoodData Central — the reference nutrient database.

Connections

• All Herbs
• Houttuynia cordata (Fish Mint) — the main topic page: botany, names, chemistry, preparations and dosage.
• The Injectable Reactions and Why Route Matters — the best-documented fact about this plant.
• Antiviral and Respiratory Research — the reason for modern interest, examined honestly.
• Houttuynia as Food and in Traditional Medicine — the exposure with the long record.
• Safety: Family Questions, Dose and Unknowns — the aristolochic acid question, answered in both directions.
• Vietnamese Coriander — the other aldehyde-driven herb on the same platter.
• Perilla Benefits — tía tô, fish mint's constant companion, with a comparable evidence shape.
• Perilla: Allergy and Rhinitis — the neighbouring rhinitis literature.
• Vietnamese Balm — kinh giới, the third of the raw-herb trio.
• Which Tinospora, and Adulteration — the site's other family-substitution and identity case.
• Elderberry for Cold and Flu — a herb that has been through placebo-controlled trials.
• Andrographis for Cold and Flu — another, with multiple randomised trials.
• Influenza — the condition most often invoked for this plant.
• Anaphylaxis — what the injectable reactions were.
• Kidney Disease — the organ at the centre of the aristolochic acid story.
• Quercetin — the flavonoid family behind most of this plant's borrowed citations.
• Potassium — background for the diuretic and heavy-tea question.

Back to Table of Contents